Literature DB >> 2473362

Specificity of tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) for the diagnosis of hepatic metastases from large bowel cancers.

V Abbasciano1, F Levato, G Zavagli.   

Abstract

In 98 patients affected by colorectal cancer (43 patients with colon cancer, 55 patients with rectosigmoid cancer) the specificity of some tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) has been tested in evidencing the coexistence of liver metastases and the site of the primary tumor, i.e. the rectosigmoid region (rectum + 15 cm of the adjacent sigmoid colon) vs the rest of the colon. Liver metastases, present in 19 patients with colon cancer and in 24 with recto-sigmoid cancer, were previously ascertained by various instrumental investigations. Unlike previous studies which indicated CEA or alpha-FP as the most reliable markers to suggest the coexistence of liver metastases in such patients, the reported results allow the following sequence, in decreasing order of sensitivity, to be proposed: gamma-GT; FpA; CEA and GICA to a similar degree; TPA, which increases only when liver metastases from colon cancer are present; lastly, alpha-FP, which rises only in very few cases of massive hepatic involvement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473362     DOI: 10.1007/bf02985235

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  13 in total

1.  Specificity of fibrinopeptide A (FpA) as a marker for gastrointestinal cancers before and after surgery.

Authors:  V Abbasciano; F Levato; G Zavagli
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

2.  Letter: Radioimmunoassay of alpha-fetoprotein in gastrointestinal diseases.

Authors:  R Masseyeff; J F Rey; J P Cassuto; B Krebs; J Delmont
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

3.  Carcinoembryonic antigen levels as an indicator of the primary site in metastatic disease of unknown origin.

Authors:  M Koch; T A McPherson
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

4.  Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer.

Authors:  H F Sears; M Herlyn; B Del Villano; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

5.  Specific antigen in serum of patients with colon carcinoma.

Authors:  H Koprowski; M Herlyn; Z Steplewski; H F Sears
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

6.  Hepatic resection for metastasis from colorectal cancer.

Authors:  F F Attiyeh; H J Wanebo; M W Stearns
Journal:  Dis Colon Rectum       Date:  1978-04       Impact factor: 4.585

7.  Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.

Authors:  A Shani; M J O'Connell; C G Moertel; A J Schutt; A Silvers; V L Go
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

8.  Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary.

Authors:  R A Oberfield; J A McCaffrey; J Polio; M E Clouse; T Hamilton
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.

Authors:  F W Peuscher; F J Cleton; L Armstrong; E A Stoepman-van Dalen; J A van Mourik; W G van Aken
Journal:  J Lab Clin Med       Date:  1980-07

10.  The diagnostic significance of serum alpha-fetoprotein.

Authors:  A Azzopardi
Journal:  Tumori       Date:  1974 May-Jun
View more
  1 in total

1.  Effect of WeiJia on carbon tetrachloride induced chronic liver injury.

Authors:  Pik-Yuen Cheung; Qi Zhang; Ya-Ou Zhang; Gan-Rong Bai; Marie Chia-Mi Lin; Bernard Chan; Chi-Chun Fong; Lin Shi; Yue-Feng Shi; Jay Chun; Hsiang-Fu Kung; Mengsu Yang
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.